Tenax Therapeutics, Inc. (NASDAQ: TENX), a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today announced the appointment of Paula Bokesch, M.D. as Chief Medical Officer, effective February 14, 2015. In addition, Tenax announced positive enrollment progress for the ongoing late-stage trials for levosimendan.
Help employers find you! Check out all the jobs and post your resume.
